Lialda’s Pediatric label approval (SHIRE to Takeda)-
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022000s019lbl.pdf
Eventual ADAKVEO market approval (SELEXYS Pharmaceuticals to Novartis)
https://www.novartis.com/news/media-releases/novartis-acquires-selexys-pharmaceuticals-corporation-and-selg1-antibody-reduction-pain-crises-sickle-cell-disease-scd
Latest client’s milestone in current development-
https://www.biospace.com/article/releases/renovion-announces-positive-top-line-results-from-phase-2-climb-study-of-arina-1-rvn-301-in-patients-with-non-cystic-fibrosis-bronchiectasis/